Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Stacey C. Sigmon, Adam Bisaga, Edward V. Nunes, Patrick G. O'Connor, Thomas Kosten & George Woody. (2012) Opioid Detoxification and Naltrexone Induction Strategies: Recommendations for Clinical Practice. The American Journal of Drug and Alcohol Abuse 38:3, pages 187-199.
Read now
Read now
Paolo Mannelli, Kathleen S Peindl & Li-Tzy Wu. (2011) Pharmacological enhancement of naltrexone treatment for opioid dependence: a review. Substance Abuse and Rehabilitation 2, pages 113-123.
Read now
Read now
Tracie J. Gardner & Thomas R. Kosten. (2007) Therapeutic options and challenges for substances of abuse. Dialogues in Clinical Neuroscience 9:4, pages 431-445.
Read now
Read now
Sandra D Comer, Maria A Sullivan & Gary K Hulse. (2007) Sustained-release naltrexone: novel treatment for opioid dependence. Expert Opinion on Investigational Drugs 16:8, pages 1285-1294.
Read now
Read now
Benjamin R. Nordstrom & Frances R. Levin. (2007) Treatment of Cannabis Use Disorders: A Review of the Literature. American Journal on Addictions 16:5, pages 331-342.
Read now
Read now
Maria A. Sullivan, Jami L. Rothenberg, Suzanne K. Vosburg, Sarah H. Church, Shara J. Feldman, Eva M. Epstein, Herbert D. Kleber & Edward V. Nunes. (2006) Predictors of Retention in Naltrexone Maintenance for Opioid Dependence: Analysis of a Stage I Trial. American Journal on Addictions 15:2, pages 150-159.
Read now
Read now
Beth K Boyarsky & Elinore F. McCance-Katz. (2000) Improving the Quality of Substance Dependency Treatment with Pharmacotherapy. Substance Use & Misuse 35:12-14, pages 2095-2125.
Read now
Read now
William Dejong. (1994) Relapse Prevention: An Emerging Technology for Promoting Long-Term Drug Abstinence. International Journal of the Addictions 29:6, pages 681-705.
Read now
Read now
Thomas R. Kosten, Charles Morgan & Herbert D. Kleber. (1991) Treatment of Heroin Addicts Using Buprenorphine. The American Journal of Drug and Alcohol Abuse 17:2, pages 119-128.
Read now
Read now
Thomas R. Kosten & Arthur Margolin. (1990) New Developments in Opioid Abuse Treatment. Annals of Clinical Psychiatry 2:4, pages 245-250.
Read now
Read now
Thomas R. Kosten, Behnaz Jalali, John H. Steidl & Herbert D. Kleber. (1987) Relationship of Marital Structure and Interactions to Opiate Abuse Relapse. The American Journal of Drug and Alcohol Abuse 13:4, pages 387-399.
Read now
Read now
Herbert D. Kleber, Mark Topazian, Joseph Gaspari, Charles E. Riordan & Thomas Kosten. (1987) Clonidine and Naltrexone in the Outpatient Treatment of Heroin Withdrawal. The American Journal of Drug and Alcohol Abuse 13:1-2, pages 1-17.
Read now
Read now
Thomas R. Kosten, Peter Novak & Herbert D. Kleber. (1984) Perceived Marital and Family Environment of Opiate Addicts. The American Journal of Drug and Alcohol Abuse 10:4, pages 491-501.
Read now
Read now
Articles from other publishers (39)
Norsyifa Harun, Nur Azzalia Kamaruzaman, Zarif Mohamed Sofian & Zurina Hassan. (2022) Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy. Neuroscience Letters 773, pages 136500.
Crossref
Crossref
Benjamin R. Nordstrom, Sarah C. Akerman & Frances R. Levin. 2015. Psychiatry. Psychiatry
1458
1469
.
Erin Kelty, Hanh Ngo & Gary Hulse. (2012) Assessing the usefulness of health data linkage in obtaining adverse event data in a randomised controlled trial of oral and implant naltrexone in the treatment of heroin dependence. Clinical Trials 10:1, pages 170-180.
Crossref
Crossref
Robert Swift & Lorenzo Leggio. 2013. Terapia uzależnień. Metody oparte na dowodach naukowych. Terapia uzależnień. Metody oparte na dowodach naukowych.
Devki Sukhtankar & Mei-Chuan Ko. 2013. Research and Development of Opioid-Related Ligands. Research and Development of Opioid-Related Ligands
393
416
.
Anthony DeFulio & Kenneth Silverman. (2012) The use of incentives to reinforce medication adherence. Preventive Medicine 55, pages S86-S94.
Crossref
Crossref
Jeanette M. Tetrault & David A. Fiellin. (2012) Current and Potential Pharmacological Treatment Options for Maintenance Therapy in Opioid-Dependent Individuals. Drugs 72:2, pages 217-228.
Crossref
Crossref
Donna M. Sudak. 2011. Combining CBT and Medication. Combining CBT and Medication
209
234
.
Sandra D. Comer, Warren K. Bickel, Richard Yi, Harriet de Wit, Stephen T. Higgins, Galen R. Wenger, Chris-Ellyn Johanson & Mary Jeanne Kreek. (2010) Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society. Behavioural Pharmacology 21:4, pages 251-277.
Crossref
Crossref
Robert Swift & Lorenzo Leggio. 2009. Evidence-Based Addiction Treatment. Evidence-Based Addiction Treatment
287
310
.
Gary K. Hulse, Sandra D. Comer & Maria A. Sullivan. 2009. Opiate Receptors and Antagonists. Opiate Receptors and Antagonists
675
688
.
Maria A. Sullivan, Suzanne K. Vosburg & Sandra D. Comer. (2006) Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin. Psychopharmacology 189:1, pages 37-46.
Crossref
Crossref
Marina Perfumi, Manuela Santoni, Andrea Cippitelli, Roberto Ciccocioppo, Rino Froldi & Maurizio Massi. (2006)
Hypericum perforatum
CO
2
Extract and Opioid Receptor Antagonists Act Synergistically to Reduce Ethanol Intake in Alcohol‐Preferring Rats
. Alcoholism: Clinical and Experimental Research 27:10, pages 1554-1562.
Crossref
Crossref
William Fals-Stewart & Timothy J. O'Farrell. (2003) Behavioral family counseling and naltrexone for male opioid-dependent patients.. Journal of Consulting and Clinical Psychology 71:3, pages 432-442.
Crossref
Crossref
Cindy Parks Thomas, Stanley S Wallack, Sue Lee, Dennis McCarty & Robert Swift. (2003) Research to practice. Journal of Substance Abuse Treatment 24:1, pages 1-11.
Crossref
Crossref
Jami L Rothenberg, Maria A Sullivan, Sarah H Church, Angela Seracini, Eric Collins, Herbert D Kleber & Edward V Nunes. (2002) Behavioral naltrexone therapy. Journal of Substance Abuse Treatment 23:4, pages 351-360.
Crossref
Crossref
Catherine McGregor, Robert Ali, Jason M White, Peter Thomas & Linda Gowing. (2002) A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months. Drug and Alcohol Dependence 68:1, pages 5-14.
Crossref
Crossref
Edward V. Nunes, Kathleen M. Carroll & Warren K. Bickel. (2002) Clinical and translational research: Introduction to the special issue.. Experimental and Clinical Psychopharmacology 10:3, pages 155-158.
Crossref
Crossref
Agustín Madoz-Gúrpide, Enriqueta Ochoa & Enrique Baca-García. (2002) Revisión de la efectividad de los programas de mantenimiento con naltrexona: parámetros de evaluación, perfiles de indicación y factores asociados. Medicina Clínica 119:9, pages 351-355.
Crossref
Crossref
CHRISTOPHER J. WELSH & JOSEPH LIBERTO. (2001) The Use of Medication for Relapse Prevention in Substance Dependence Disorders. Journal of Psychiatric Practice 7:1, pages 15-31.
Crossref
Crossref
Damaris J. Rohsenow, Suzanne M. Colby, Peter M. Monti, Robert M. Swift, Rosemarie A. Martin, Timothy I. Mueller, Alan Gordon & Cheryl A. Eaton. (2006) Predictors of Compliance with Naltrexone Among Alcoholics. Alcoholism: Clinical and Experimental Research 24:10, pages 1542-1549.
Crossref
Crossref
Roberto Ciccocioppo, Stefania Angeletti, Izabela Panocka & Maurizio Massi. (2000) Nociceptin/orphanin FQ and drugs of abuse. Peptides 21:7, pages 1071-1080.
Crossref
Crossref
Joseph J. Zealberg & Kathleen T. Brady. (1999) SUBSTANCE ABUSE AND EMERGENCY PSYCHIATRY. Psychiatric Clinics of North America 22:4, pages 803-817.
Crossref
Crossref
Sarah Welch & John Strang. (2018) Pharmacotherapy in the treatment of drug dependence: options to strengthen effectiveness. Advances in Psychiatric Treatment 5:6, pages 427-434.
Crossref
Crossref
Peggy Compton. (1998) Pain Tolerance in Opioid Addicts On and Off Naltrexone Pharmacotherapy. Journal of Pain and Symptom Management 16:1, pages 21-28.
Crossref
Crossref
Albert Seoane, Genís Carrasco, Lluís Cabré, Ana Puiggrós, Eustaqui Hernández, Miguel Álvarez, Josep Costa, Ricard Molina & Gaudi Sobrepere. (2018) Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success. British Journal of Psychiatry 171:4, pages 340-345.
Crossref
Crossref
Elizabeth A. Warner, Thomas R. Kosten & Patrick G. O'Connor. (1997) PHARMACOTHERAPY FOR OPIOID AND COCAINE ABUSE. Medical Clinics of North America 81:4, pages 909-925.
Crossref
Crossref
Marc A. SchuckitMarc A. Schuckit. 1995. Drug and Alcohol Abuse. Drug and Alcohol Abuse
303
349
.
Steven M. Mirin, Roger D. Weiss & Shelly F. Greenfield. 1991. The Practitioner’s Guide to Psychoactive Drugs. The Practitioner’s Guide to Psychoactive Drugs
243
316
.
Colin Brewer. (2018) Combining Pharmacological Antagonists and Behavioural Psychotherapy in Treating Addictions. British Journal of Psychiatry 157:1, pages 34-40.
Crossref
Crossref
Thomas R. Kosten, John H. Krystal, Dennis S. Charney, Lawrence H. Price, Charles H. Morgan & Herbert D. Kleber. (1990) Opioid antagonist challenges in buprenorphine maintained patients. Drug and Alcohol Dependence 25:1, pages 73-78.
Crossref
Crossref
Margaret A. Compton. (2016) A Rogerian View of Drug Abuse: Implications for Nursing. Nursing Science Quarterly 2:2, pages 98-105.
Crossref
Crossref
Thomas R. Kosten, Herbert D. Kleber & Charles Morgan. (1989) Role of opioid antagonists in treating intravenous cocaine abuse. Life Sciences 44:13, pages 887-892.
Crossref
Crossref
Marc A. SchuckitMarc A. Schuckit. 1989. Drug and Alcohol Abuse. Drug and Alcohol Abuse
256
292
.
EUGENIA VINING, THOMAS R. KOSTEN & HERBERT D. KLEBER. (2010) Clinical Utility of Rapid Clonidine‐naltrcxone Detoxification for Opioid Abusers. British Journal of Addiction 83:5, pages 567-575.
Crossref
Crossref
D. Ladewig. 1987. Abhängigkeit und Sucht. Abhängigkeit und Sucht
359
397
.
Thomas R. Kosten, Mary-Jeanne Kreek, Jayanthi Ragunath & Herbert D. Kleber. (1986) A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts. Life Sciences 39:1, pages 55-59.
Crossref
Crossref
Herbert D. Kleber, Thomas R. Kosten, Joseph Gaspari & Mark Topazian. (1985) Nontolerance to the opioid antagonism of naltrexone. Biological Psychiatry 20:1, pages 66-72.
Crossref
Crossref
Thomas R. Kosten, Bruce J. Rounsaville & Herbert D. Kleber. (1984) Relationship of depression to clonidine detoxification of opiate addicts. Comprehensive Psychiatry 25:5, pages 503-508.
Crossref
Crossref